{
  "uuid": "5ad1f43d-def0-4b65-ac78-c0c00e053049",
  "created_at": "2025-11-22 19:57:39",
  "raw_json": {
    "article_author": null,
    "article_headline": null,
    "article_modified": null,
    "article_published": null,
    "article_section": null,
    "article_tags": null,
    "canonical_url": "https://www.r-bloggers.com/2025/09/faster-clinical-trial-reporting-a-beginners-guide-to-implementing-cdisc-sdtm-and-adam-standards-with-open-source-r-packages/",
    "crawled_at": "2025-11-22T10:42:52.029707",
    "external_links": [
      {
        "href": "https://pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/faster_clinical_trial_reporting.html",
        "text": "pharmaverse blog"
      },
      {
        "href": "http://r-posts.com/",
        "text": "here"
      },
      {
        "href": "https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/",
        "text": "Declaration of Helsinki"
      },
      {
        "href": "https://www.socra.org/blog/clinicaltrials-registration-results-reporting/",
        "text": "SOCRA"
      },
      {
        "href": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4508873/",
        "text": "BMJ/PMC analysis"
      },
      {
        "href": "https://pubmed.ncbi.nlm.nih.gov/28207928/",
        "text": "Cochrane review, 2017"
      },
      {
        "href": "https://www.cdisc.org/",
        "text": "Clinical Data Interchange Standards Consortium (CDISC)"
      },
      {
        "href": "https://www.cdisc.org/standards/foundational/cdash",
        "text": "CDASH"
      },
      {
        "href": "https://www.cdisc.org/standards/foundational/sdtmig",
        "text": "SDTM Implementation Guide"
      },
      {
        "href": "https://www.cdisc.org/standards/foundational/adam",
        "text": "ADaM Implementation Guide"
      },
      {
        "href": "https://pharmaverse.org/e2eclinical/",
        "text": "https://pharmaverse.org/e2eclinical/"
      },
      {
        "href": "https://www.cdisc.org/kb/ecrf",
        "text": "CDASH data"
      },
      {
        "href": "https://pharmaverse.github.io/pharmaversesdtm/",
        "text": "pharmaversesdtm"
      },
      {
        "href": "https://pharmaverse.github.io/pharmaverseadam/",
        "text": "pharmaverseadam"
      },
      {
        "href": "https://insightsengineering.github.io/random.cdisc.data/main/",
        "text": "{random.cdisc.data}"
      },
      {
        "href": "https://insightsengineering.github.io/tlg-catalog/",
        "text": "TLG Catalogue"
      },
      {
        "href": "https://pharmaverse.org/",
        "text": "Pharmaverse"
      },
      {
        "href": "https://www.cdisc.org/standards/foundational",
        "text": "CDISC"
      },
      {
        "href": "https://insightsengineering.github.io/tlg-catalog/stable/",
        "text": "TLG Catalog"
      },
      {
        "href": "https://github.com/pharmaverse/blog/tree/main/posts/2025-05-12_faster_clinical_trial_reporting.../faster_clinical_trial_reporting.qmd",
        "text": "Source"
      },
      {
        "href": "https://pharmaverse.github.io/blog/session_info.html",
        "text": "Session info"
      },
      {
        "href": "https://creativecommons.org/licenses/by/4.0/",
        "text": "CC BY 4.0"
      },
      {
        "href": "https://pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/faster_clinical_trial_reporting.html",
        "text": "https://pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/faster_clinical_trial_reporting.html"
      },
      {
        "href": "https://pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/faster_clinical_trial_reporting.html",
        "text": "pharmaverse blog"
      },
      {
        "href": "https://feedburner.google.com/fb/a/mailverify?uri=RBloggers",
        "text": "daily e-mail updates"
      },
      {
        "href": "https://www.r-project.org/",
        "text": "R"
      },
      {
        "href": "https://www.r-users.com/",
        "text": "Click here if you're looking to post or find an R/data-science job"
      },
      {
        "href": "http://r-posts.com/",
        "text": "here"
      }
    ],
    "h1_title": "R-bloggers",
    "html_title": "Faster Clinical Trial Reporting: A Beginner’s Guide to Implementing CDISC SDTM and ADaM Standards with Open-Source R Packages | R-bloggers",
    "images": [
      {
        "alt": null,
        "base64": "data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7",
        "src": "https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif"
      },
      {
        "alt": null,
        "base64": null,
        "src": "https://i1.wp.com/pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/images/1.png?w=578&ssl=1"
      },
      {
        "alt": null,
        "base64": "data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7",
        "src": "https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif"
      },
      {
        "alt": null,
        "base64": null,
        "src": "https://i0.wp.com/pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/images/2.png?w=578&ssl=1"
      },
      {
        "alt": null,
        "base64": "data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7",
        "src": "https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif"
      },
      {
        "alt": null,
        "base64": null,
        "src": "https://i0.wp.com/pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/images/3.png?w=578&ssl=1"
      },
      {
        "alt": null,
        "base64": "data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7",
        "src": "https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif"
      },
      {
        "alt": null,
        "base64": null,
        "src": "https://i2.wp.com/pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/images/4.png?w=578&ssl=1"
      },
      {
        "alt": null,
        "base64": "data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7",
        "src": "https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif"
      },
      {
        "alt": "data-recalc-dims=",
        "base64": null,
        "src": "https://i0.wp.com/pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/images/5.png?w=578&ssl=1"
      }
    ],
    "internal_links": [
      {
        "href": "https://www.r-bloggers.com/author/fabian-hee/",
        "text": "Fabian Hee"
      },
      {
        "href": "https://www.r-bloggers.com/category/r-bloggers/",
        "text": "R bloggers"
      },
      {
        "href": "https://www.r-bloggers.com/",
        "text": "R-bloggers"
      },
      {
        "href": "https://www.r-bloggers.com/contact-us/",
        "text": "here"
      },
      {
        "href": "https://www.r-bloggers.com/add-your-blog/",
        "text": "click here"
      },
      {
        "href": "https://www.r-bloggers.com/",
        "text": "R-bloggers.com"
      },
      {
        "href": "https://www.r-bloggers.com/how-to-learn-r-2/",
        "text": "learning R"
      },
      {
        "href": "https://www.r-bloggers.com/add-your-blog/",
        "text": "click here"
      }
    ],
    "lang": "en-US",
    "main_html": "<article class=\"post-395364 post type-post status-publish format-standard hentry category-r-bloggers\">\n<header class=\"post-header\">\n<h1 class=\"entry-title\">Faster Clinical Trial Reporting: A Beginner’s Guide to Implementing CDISC SDTM and ADaM Standards with Open-Source R Packages</h1>\n<p class=\"meta post-meta\">Posted on <span class=\"updated\">September 11, 2025</span>  by <span class=\"vcard author\"><a class=\"fn\" href=\"https://www.r-bloggers.com/author/fabian-hee/\">Fabian Hee</a></span>  in <a href=\"https://www.r-bloggers.com/category/r-bloggers/\" rel=\"category tag\">R bloggers</a> | 0 Comments</p>\n</header>\n<div class=\"entry clearfix\">\n<!-- \n<div style=\"min-height: 30px;\">\n[social4i size=\"small\" align=\"align-left\"]\n</div>\n-->\n<div style=\"border: 1px solid; background: none repeat scroll 0 0 #EDEDED; margin: 1px; font-size: 12px;\">\n[This article was first published on  <strong><a href=\"https://pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/faster_clinical_trial_reporting.html\"> pharmaverse blog</a></strong>, and kindly contributed to <a href=\"https://www.r-bloggers.com/\" rel=\"nofollow\">R-bloggers</a>].  (You can report issue about the content on this page <a href=\"https://www.r-bloggers.com/contact-us/\">here</a>)\n<hr/>Want to share your content on R-bloggers?<a href=\"https://www.r-bloggers.com/add-your-blog/\" rel=\"nofollow\"> click here</a> if you have a blog, or <a href=\"http://r-posts.com/\" rel=\"nofollow\"> here</a> if you don't.\n</div>\n\n<!-- Share buttons by mashshare.net - Version: 4.0.47-->\n<!--------------- typical setup ----------------->\n<!--------------- post begins here ----------------->\n<p>Clinical trials are a crucial component of the pharmaceutical industry, providing the evidence needed to demonstrate the safety, efficacy, and overall benefit of new drugs or treatments.</p>\n<p>Clinical trials reporting, a detailed process in itself, is guided by regulatory agencies like the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the International Conference on Harmonisation (ICH).</p>\n<p>The results of these trials must be carefully reported to protect public health and foster trust in the pharmaceutical industry. Pharmaverse and R directly support this need by providing open-source, transparent, and standardized tools that enable consistent data handling and reporting.</p>\n<section class=\"level2\" id=\"current-challenges\">\n<h2 class=\"anchored\" data-anchor-id=\"current-challenges\">Current challenges</h2>\n<p>Clinical trials face several challenges in their current state, which can be broadly categorized into three key areas:</p>\n<section class=\"level3\" id=\"ethical-and-transparency-issues\">\n<h3 class=\"anchored\" data-anchor-id=\"ethical-and-transparency-issues\">Ethical and Transparency Issues</h3>\n<p>International ethical standards, including the <a href=\"https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/\" rel=\"nofollow\" target=\"_blank\">Declaration of Helsinki</a>, emphasize that the results of all clinical trials—whether positive, negative, or inconclusive—should be made publicly accessible. Nevertheless, empirical studies show that compliance remains inconsistent. In particular, early-phase or smaller studies, as well as trials with negative outcomes, are less likely to be reported in a timely or visible manner (<a href=\"https://www.socra.org/blog/clinicaltrials-registration-results-reporting/\" rel=\"nofollow\" target=\"_blank\">SOCRA</a>; <a href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4508873/\" rel=\"nofollow\" target=\"_blank\">BMJ/PMC analysis</a>). Furthermore, evidence suggests that industry sponsorship can introduce bias at various stages of trial design, analysis, and reporting, which reinforces the importance of transparent dissemination of all findings (<a href=\"https://pubmed.ncbi.nlm.nih.gov/28207928/\" rel=\"nofollow\" target=\"_blank\">Cochrane review, 2017</a>).</p>\n</section>\n<section class=\"level3\" id=\"cost-and-efficiency-challenges\">\n<h3 class=\"anchored\" data-anchor-id=\"cost-and-efficiency-challenges\">Cost and Efficiency Challenges</h3>\n<p>Clinical trials are expensive, often exceeding hundreds of millions of dollars, and this can inhibit the development of drugs for rare diseases where the return on investment is limited by the small size of the patient population. Failure in clinical trials – especially in late phase trials that often include upwards of 1000 patients – can incur huge losses, compounded by the complex and varying nature of global regulations around them.</p>\n</section>\n<section class=\"level3\" id=\"data-and-reproducibility-concerns\">\n<h3 class=\"anchored\" data-anchor-id=\"data-and-reproducibility-concerns\">Data and Reproducibility Concerns</h3>\n<p>Reproducibility is key for independent verification of clinical trial results. Differences in data collection methods, formats, and methodologies often hinder cross-study comparisons, especially if a study was not designed with international standards that are consistent and reproducible.</p>\n</section>\n</section>\n<section class=\"level2\" id=\"pharmaceutical-standards\">\n<h2 class=\"anchored\" data-anchor-id=\"pharmaceutical-standards\">Pharmaceutical Standards</h2>\n<p>The <a href=\"https://www.cdisc.org/\" rel=\"nofollow\" target=\"_blank\"><strong>Clinical Data Interchange Standards Consortium (CDISC)</strong></a> provides globally accepted data standards, which are a set of guidelines and models used to standardize the collection, exchange, and analysis of clinical trial data. These standards aim to improve efficiency, data quality, and interoperability across various clinical research areas.</p>\n<p>In this article specifically, the key CDISC Standards we are going to highlight are Clinical Data Acquisition Standards Harmonization (CDASH), Study Data Tabulation Model (SDTM) and Analysis Data Model (ADaM).</p>\n<section class=\"level3\" id=\"cdash---clinical-data-acquisition-standards-harmonization\">\n<h3 class=\"anchored\" data-anchor-id=\"cdash---clinical-data-acquisition-standards-harmonization\">CDASH – Clinical Data Acquisition Standards Harmonization</h3>\n<p><a href=\"https://www.cdisc.org/standards/foundational/cdash\" rel=\"nofollow\" target=\"_blank\">CDASH</a> provides <strong><em>guidelines for standardized data collection</em></strong> across clinical trial studies. It ensures that data collected at clinical sites is structured, consistent, and easily translatable into regulatory submission formats like SDTM.</p>\n</section>\n<section class=\"level3\" id=\"sdtm---study-data-tabulation-model\">\n<h3 class=\"anchored\" data-anchor-id=\"sdtm---study-data-tabulation-model\">SDTM – Study Data Tabulation Model</h3>\n<p><a href=\"https://www.cdisc.org/standards/foundational/sdtmig\" rel=\"nofollow\" target=\"_blank\">SDTM Implementation Guide</a> is a standard for <strong>structuring and organizing clinical study datasets</strong> for regulatory submissions (e.g., to the FDA, EMA). SDTM data is generally treated by the FDA as the <strong>raw or source data</strong>, since it represents the collected study information in a standardized format.</p>\n<p>Importantly, SDTM <strong>restructures the collected data</strong> for consistency and transparency across studies, but it does <strong>not derive or create new analysis variables</strong> — that role is covered by ADaM.</p>\n</section>\n<section class=\"level3\" id=\"adam---analysis-data-model\">\n<h3 class=\"anchored\" data-anchor-id=\"adam---analysis-data-model\">ADaM – Analysis Data Model</h3>\n<p><a href=\"https://www.cdisc.org/standards/foundational/adam\" rel=\"nofollow\" target=\"_blank\">ADaM Implementation Guide</a> ensures traceability from SDTM data to analysis-ready datasets. This model establishes a <strong><em>standardized way to create datasets for statistical analysis</em></strong> from SDTM organized data, facilitating efficient analysis and reporting.</p>\n</section>\n</section>\n<section class=\"level2\" id=\"the-role-of-r-in-clinical-trials\">\n<h2 class=\"anchored\" data-anchor-id=\"the-role-of-r-in-clinical-trials\">The Role of R in Clinical Trials</h2>\n<p>Nowadays, R is widely used in clinical trial analysis due to its flexibility, powerful statistical capabilities, and strong support for regulatory compliance. R provides:</p>\n<ul>\n<li><strong>Robust Statistical Analysis</strong> used for survival analysis, mixed models, and Bayesian statistics.</li>\n<li><strong>Data Cleaning &amp; Transformation</strong> facilitated by specialized packages and modeling tools.</li>\n<li><strong>Reproducibility &amp; Open Source Solutions</strong> to ensure that clinical reports and submissions can be automated, reducing errors.</li>\n<li><strong>Integration with CDISC Standards</strong> with the help of various R packages that can structure data according to SDTM and ADaM requirements.</li>\n</ul>\n</section>\n<section class=\"level2\" id=\"pharmaverse\">\n<h2 class=\"anchored\" data-anchor-id=\"pharmaverse\">Pharmaverse</h2>\n<p>Pharmaverse is a collaborative open-source ecosystem of tools for clinical trial data processing and regulatory compliance, currently consisting mainly of R packages but now also including emerging Python software. It provides resources that streamline the implementation of CDISC standards such as SDTM, ADaM, and Define-XML.</p>\n<ul>\n<li>Key Pharmaverse Packages:\n<ul>\n<li><strong><code>{sdtm.oak}</code></strong> – Helps in structuring SDTM datasets.</li>\n<li><strong><code>{admiral}</code></strong> – Facilitates ADaM dataset creation.</li>\n<li><strong><code>{teal}</code></strong> – Builds interactive R/Shiny dashboards for exploratory clinical data analysis.</li>\n</ul></li>\n<li>Related R Packages:\n<ul>\n<li><strong><code>{rtables}</code></strong> – Creates regulatory-compliant tables for clinical reports.</li>\n<li><strong><code>{tern}</code></strong> – Creates regulatory-compliant tables/graphs for clinical reports.</li>\n</ul></li>\n</ul>\n<p>These are not the only packages that are used, but these are the ones that will be referenced within this blogpost.</p>\n<p>Pharmaverse doesn’t have a dedicated CDASH package, but its metadata-driven approach means you can still work with CDASH concepts to connect source data collection to SDTM mapping.</p>\n<p>A more comprehensive list of packages can be found here: <a class=\"uri\" href=\"https://pharmaverse.org/e2eclinical/\" rel=\"nofollow\" target=\"_blank\">https://pharmaverse.org/e2eclinical/</a></p>\n</section>\n<section class=\"level2\" id=\"data-pipeline\">\n<h2 class=\"anchored\" data-anchor-id=\"data-pipeline\">Data Pipeline</h2>\n<p>In Clinical Trial Reporting, the data pipeline could follow this standard:</p>\n<p><img class=\"img-fluid\" data-lazy-src=\"https://i1.wp.com/pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/images/1.png?w=578&amp;ssl=1\" data-recalc-dims=\"1\" src=\"https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif\"/><noscript><img class=\"img-fluid\" data-recalc-dims=\"1\" src=\"https://i1.wp.com/pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/images/1.png?w=578&amp;ssl=1\"/></noscript></p>\n<p>The raw data from patients is collected according to CDASH guidelines, then processed with SDTM and ADaM standards to produce related Tables, Listings, and Graphs/Figures outputs that correspond to all aspects of a specific clinical trial.</p>\n<p>Starting with the <a href=\"https://www.cdisc.org/kb/ecrf\" rel=\"nofollow\" target=\"_blank\">CDASH data</a> from a study, the preparation process starts with <code>{sdtm.oak}</code> and <code>{sdtmchecks}</code> packages from the Pharmaverse in order to get them ready for SDTM formatted datasets.</p>\n<p>Subsequently, ADaM standards are applied on this data using the <code>{admiral}</code> package, which can then be analysed and transformed into Tables, Listings, and Graphs/Figures using non-pharmaverse (but still related) packages such as <code>{rtables}</code> and <code>{tern}</code>.</p>\n<p><img class=\"img-fluid\" data-lazy-src=\"https://i0.wp.com/pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/images/2.png?w=578&amp;ssl=1\" data-recalc-dims=\"1\" src=\"https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif\"/><noscript><img class=\"img-fluid\" data-recalc-dims=\"1\" src=\"https://i0.wp.com/pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/images/2.png?w=578&amp;ssl=1\"/></noscript></p>\n<p>The Pharmaverse contains some repositories with test data that can help visualize and make sense of this, namely <a href=\"https://pharmaverse.github.io/pharmaversesdtm/\" rel=\"nofollow\" target=\"_blank\"><code>pharmaversesdtm</code></a> and <a href=\"https://pharmaverse.github.io/pharmaverseadam/\" rel=\"nofollow\" target=\"_blank\"><code>pharmaverseadam</code></a>.</p>\n<p>There is also the <a href=\"https://insightsengineering.github.io/random.cdisc.data/main/\" rel=\"nofollow\" target=\"_blank\"><code>{random.cdisc.data}</code></a> package that can be used to generate randomized CDISC data for exploratory purposes.</p>\n<p>More information about these datasets can be found in their respective documentation sites.</p>\n</section>\n<section class=\"level2\" id=\"tables-listings-graphsfigures\">\n<h2 class=\"anchored\" data-anchor-id=\"tables-listings-graphsfigures\">Tables, Listings, Graphs/Figures</h2>\n<p>The content of clinical trial reports contains 3 different types of outputs:</p>\n<ol type=\"1\">\n<li>Tables</li>\n<li>Listings</li>\n<li>Graphs/Figures</li>\n</ol>\n<p>These outputs play a vital part to summarize the results of a clinical trial during reporting. They can summarize safety, efficacy, and exploratory outcomes (such as biomarker analyses).</p>\n<p>In the next sections, we will be using the datasets in the <code>{random.cdisc.data}</code> package to help create example outputs used in clinical trials reports. These will be split into two sections each, namely “Data Setup” and “Standard Output Generation”.</p>\n<section class=\"level3\" id=\"tables\">\n<h3 class=\"anchored\" data-anchor-id=\"tables\">Tables</h3>\n<p>In this example, we will be creating a <strong><em>Standard Adverse Events Table (AET02)</em></strong> using the <code>cadsl</code> and <code>cadae</code> datasets from the <code>random.cdisc.data</code> package (see the <a href=\"https://insightsengineering.github.io/tlg-catalog/\" rel=\"nofollow\" target=\"_blank\">TLG Catalogue</a> for reference).</p>\n<div class=\"quarto-figure quarto-figure-center\">\n<figure class=\"figure\">\n<p><img class=\"img-fluid figure-img\" data-lazy-src=\"https://i0.wp.com/pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/images/3.png?w=578&amp;ssl=1\" data-recalc-dims=\"1\" src=\"https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif\"/><noscript><img class=\"img-fluid figure-img\" data-recalc-dims=\"1\" src=\"https://i0.wp.com/pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/images/3.png?w=578&amp;ssl=1\"/></noscript></p>\n<figcaption>&gt; Adverse Events Table – AET02</figcaption>\n</figure>\n</div>\n<section class=\"level4\" id=\"data-setup\">\n<h4 class=\"anchored\" data-anchor-id=\"data-setup\">Data Setup:</h4>\n<pre>library(random.cdisc.data)\nlibrary(dplyr)\nlibrary(tern)\n\n# Ensure character variables are converted to factors so that\n# empty strings and NAs are explicit missing levels.\n\nadsl &lt;- df_explicit_na(cadsl)\nadae &lt;- df_explicit_na(cadae) %&gt;%\n  var_relabel(\n    AEBODSYS = \"MedDRA System Organ Class\",\n    AEDECOD = \"MedDRA Preferred Term\"\n  ) %&gt;%\n  filter(ANL01FL == \"Y\")\n\n# Define the split function\nsplit_fun &lt;- drop_split_levels</pre>\n</section>\n<section class=\"level4\" id=\"aet02-output-generation\">\n<h4 class=\"anchored\" data-anchor-id=\"aet02-output-generation\">AET02 Output Generation:</h4>\n<pre># Standard Table for AET02 --------------------------------------------------------------\nlyt &lt;- basic_table(show_colcounts = TRUE) %&gt;%\n  split_cols_by(var = \"ACTARM\") %&gt;%\n  add_overall_col(label = \"All Patients\") %&gt;%\n  analyze_num_patients(\n    vars = \"USUBJID\",\n    .stats = c(\"unique\", \"nonunique\"),\n    .labels = c(\n      unique = \"Total number of patients with at least one adverse event\",\n      nonunique = \"Overall total number of events\"\n    )\n  ) %&gt;%\n  split_rows_by(\n    \"AEBODSYS\",\n    child_labels = \"visible\",\n    nested = FALSE,\n    split_fun = split_fun,\n    label_pos = \"topleft\",\n    split_label = obj_label(adae$AEBODSYS)\n  ) %&gt;%\n  summarize_num_patients(\n    var = \"USUBJID\",\n    .stats = c(\"unique\", \"nonunique\"),\n    .labels = c(\n      unique = \"Total number of patients with at least one adverse event\",\n      nonunique = \"Total number of events\"\n    )\n  ) %&gt;%\n  count_occurrences(\n    vars = \"AEDECOD\",\n    .indent_mods = -1L\n  ) %&gt;%\n  append_varlabels(adae, \"AEDECOD\", indent = 1L)\n\nresult &lt;- build_table(lyt, df = adae, alt_counts_df = adsl)\n\nresult</pre>\n</section>\n</section>\n<section class=\"level3\" id=\"listings\">\n<h3 class=\"anchored\" data-anchor-id=\"listings\">Listings</h3>\n<p>In this example, we will be creating a <strong><em>Standard Listing of Preferred Terms, Lowest Level Terms, and Investigator-Specified Adverse Event Terms</em></strong> <strong><em>(AEL01)</em></strong> using the <code>{cadae}</code> dataset from the <code>{random.cdisc.data}</code> package.</p>\n<div class=\"quarto-figure quarto-figure-center\">\n<figure class=\"figure\">\n<p><img class=\"img-fluid figure-img\" data-lazy-src=\"https://i2.wp.com/pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/images/4.png?w=578&amp;ssl=1\" data-recalc-dims=\"1\" src=\"https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif\"/><noscript><img class=\"img-fluid figure-img\" data-recalc-dims=\"1\" src=\"https://i2.wp.com/pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/images/4.png?w=578&amp;ssl=1\"/></noscript></p>\n<figcaption>&gt; Listing of Preferred Terms, Lowest Level Terms, and Investigator-Specified Adverse Event Terms - AEL01</figcaption>\n</figure>\n</div>\n<section class=\"level4\" id=\"data-setup-1\">\n<h4 class=\"anchored\" data-anchor-id=\"data-setup-1\">Data Setup:</h4>\n<pre>library(random.cdisc.data)\nlibrary(dplyr)\nlibrary(rlistings)\n\nout &lt;- cadae %&gt;%\n  select(AESOC, AEDECOD, AELLT, AETERM) %&gt;%\n  unique()\n\nvar_labels(out) &lt;- c(\n  AESOC = \"MedDRA System Organ Class\",\n  AEDECOD = \"MedDRA Preferred Term\",\n  AELLT = \"MedDRA Lowest Level Term\",\n  AETERM = \"Investigator-Specified\\nAdverse Event Term\"\n)</pre>\n</section>\n<section class=\"level4\" id=\"ael01-output-generation\">\n<h4 class=\"anchored\" data-anchor-id=\"ael01-output-generation\">AEL01 Output Generation:</h4>\n<pre># Standard Listing for AEL01 ------------------------------------------------------------\nlsting &lt;- as_listing(\n  out,\n  key_cols = c(\"AESOC\", \"AEDECOD\", \"AELLT\"),\n  disp_cols = names(out),\n  main_title = \"Listing of Preferred Terms, Lowest Level Terms, and Investigator-Specified Adverse Event Terms\"\n)\n\nhead(lsting, 20)</pre>\n</section>\n</section>\n<section class=\"level3\" id=\"graphsfigures\">\n<h3 class=\"anchored\" data-anchor-id=\"graphsfigures\">Graphs/Figures</h3>\n<p>In this example, we will be creating a <strong><em>Standard Plot for Subgroup Analysis of Survival Duration (FSTG02)</em></strong> using the <code>{caddtte}</code> dataset from the <code>{random.cdisc.data}</code> package.</p>\n<p><img class=\"img-fluid\" data-lazy-src=\"https://i0.wp.com/pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/images/5.png?w=578&amp;ssl=1\" src=\"https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif\"/><noscript><img 1\"=\"\" alt=\" data-recalc-dims=\" class=\"img-fluid\" src=\"https://i0.wp.com/pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/images/5.png?w=578&amp;ssl=1\"/></noscript> Subgroup Analysis of Survival Duration - FSTG02\"&gt;<br/>\n<em>&gt; Subgroup Analysis of Survival Duration - FSTG02</em></p>\n<section class=\"level4\" id=\"data-setup-2\">\n<h4 class=\"anchored\" data-anchor-id=\"data-setup-2\">Data Setup:</h4>\n<pre>library(random.cdisc.data)\nlibrary(tern)\nlibrary(dplyr)\nlibrary(forcats)\nlibrary(nestcolor)\n\npreprocess_adtte &lt;- function(adtte) {\n  # Save variable labels before data processing steps.\n  adtte_labels &lt;- var_labels(adtte)\n\n  adtte &lt;- adtte %&gt;%\n    df_explicit_na() %&gt;%\n    dplyr::filter(\n      PARAMCD == \"OS\",\n      ARM %in% c(\"B: Placebo\", \"A: Drug X\"),\n      SEX %in% c(\"M\", \"F\")\n    ) %&gt;%\n    dplyr::mutate(\n      # Reorder levels of ARM to display reference arm before treatment arm.\n      ARM = droplevels(forcats::fct_relevel(ARM, \"B: Placebo\")),\n      SEX = droplevels(SEX),\n      is_event = CNSR == 0,\n      # Convert time to MONTH\n      AVAL = day2month(AVAL),\n      AVALU = \"Months\"\n    ) %&gt;%\n    var_relabel(\n      ARM = adtte_labels[\"ARM\"],\n      SEX = adtte_labels[\"SEX\"],\n      is_event = \"Event Flag\",\n      AVAL = adtte_labels[\"AVAL\"],\n      AVALU = adtte_labels[\"AVALU\"]\n    )\n\n  adtte\n}\n\nanl &lt;- cadtte %&gt;%\n  preprocess_adtte()</pre>\n</section>\n<section class=\"level4\" id=\"fstg02-output-generation\">\n<h4 class=\"anchored\" data-anchor-id=\"fstg02-output-generation\">FSTG02 Output Generation:</h4>\n<pre># Standard Plot for FSTG02 -------------------------------------------------------\nanl1 &lt;- anl\n\ndf &lt;- extract_survival_subgroups(\n  variables = list(tte = \"AVAL\", is_event = \"is_event\", arm = \"ARM\", subgroups = c(\"SEX\", \"BMRKR2\")),\n  data = anl1\n)\n\nresult &lt;- basic_table() %&gt;%\n  tabulate_survival_subgroups(\n    df = df,\n    vars = c(\"n_tot\", \"n\", \"median\", \"hr\", \"ci\"),\n    time_unit = anl1$AVALU[1]\n  )\n\nresult\n\nplot &lt;- g_forest(tbl = result)\n\nplot</pre>\n</section>\n</section>\n</section>\n<section class=\"level2\" id=\"conclusion\">\n<h2 class=\"anchored\" data-anchor-id=\"conclusion\">Conclusion</h2>\n</section>\n<section class=\"level2\" id=\"conclusion-1\">\n<h2 class=\"anchored\" data-anchor-id=\"conclusion-1\">Conclusion</h2>\n<p>Clinical trial reporting remains fundamental to public trust and to the integrity of drug development. Nevertheless, the field continues to face persistent <strong>transparency deficits</strong>, <strong>escalating costs</strong>, and <strong>reproducibility challenges</strong>.</p>\n<p>Adopting open standards and collaborative platforms—such as the <strong>Pharmaverse</strong> ecosystem—together with broader open-source initiatives in R and related technologies, offers a practical path forward. These approaches enable greater transparency, improved efficiency, and rigorous, standards-based data practices that strengthen the scientific foundation of clinical research. Consequently, the level of trust can be further enhanced, and public welfare can be assured.</p>\n<p>Join us in part 2 of this series where we take a look at interactive clinical trials data analysis using packages that create custom shiny applications specifically for this space.</p>\n</section>\n<section class=\"level2\" id=\"resources\">\n<h2 class=\"anchored\" data-anchor-id=\"resources\">Resources</h2>\n<ul>\n<li><a href=\"https://pharmaverse.org/\" rel=\"nofollow\" target=\"_blank\">Pharmaverse</a></li>\n<li><a href=\"https://www.cdisc.org/standards/foundational\" rel=\"nofollow\" target=\"_blank\">CDISC</a></li>\n<li><a href=\"https://insightsengineering.github.io/tlg-catalog/stable/\" rel=\"nofollow\" target=\"_blank\">TLG Catalog</a></li>\n</ul>\n<!--------------- appendices go here ----------------->\n</section>\n<div class=\"cell\">\n<div class=\"cell-output-display\">\n</div>\n</div>\n<div class=\"default\" id=\"quarto-appendix\"><section class=\"level2 appendix\" id=\"last-updated\"><h2 class=\"anchored quarto-appendix-heading\">Last updated</h2><div class=\"quarto-appendix-contents\">\n<p>2025-09-12 09:11:58.119603</p>\n</div></section><section class=\"level2 appendix\" id=\"details\"><h2 class=\"anchored quarto-appendix-heading\">Details</h2><div class=\"quarto-appendix-contents\">\n<p><a href=\"https://github.com/pharmaverse/blog/tree/main/posts/2025-05-12_faster_clinical_trial_reporting.../faster_clinical_trial_reporting.qmd\" rel=\"nofollow\" target=\"_blank\">Source</a>, <a href=\"https://pharmaverse.github.io/blog/session_info.html\" rel=\"nofollow\" target=\"_blank\">Session info</a></p>\n</div></section><section class=\"quarto-appendix-contents\" id=\"quarto-reuse\"><h2 class=\"anchored quarto-appendix-heading\">Reuse</h2><div class=\"quarto-appendix-contents\"><div><a href=\"https://creativecommons.org/licenses/by/4.0/\" rel=\"nofollow\" target=\"_blank\">CC BY 4.0</a></div></div></section><section class=\"quarto-appendix-contents\" id=\"quarto-citation\"><h2 class=\"anchored quarto-appendix-heading\">Citation</h2><div><div class=\"quarto-appendix-secondary-label\">BibTeX citation:</div><pre>@online{hee2025,\n  author = {Hee, Fabian and Kouretsis, Alexandros and , APPSILON},\n  title = {Faster {Clinical} {Trial} {Reporting:} {A} {Beginner’s}\n    {Guide} to {Implementing} {CDISC} {SDTM} and {ADaM} {Standards} with\n    {Open-Source} {R} {Packages}},\n  date = {2025-09-12},\n  url = {https://pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/faster_clinical_trial_reporting.html},\n  langid = {en}\n}\n</pre><div class=\"quarto-appendix-secondary-label\">For attribution, please cite this work as:</div><div class=\"csl-entry quarto-appendix-citeas\" id=\"ref-hee2025\">\nHee, Fabian, Alexandros Kouretsis, and APPSILON. 2025. <span>“Faster\nClinical Trial Reporting: A Beginner’s Guide to Implementing CDISC SDTM\nand ADaM Standards with Open-Source R Packages.”</span> September 12,\n2025. <a href=\"https://pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/faster_clinical_trial_reporting.html\" rel=\"nofollow\" target=\"_blank\">https://pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/faster_clinical_trial_reporting.html</a>.\n</div></div></section></div>\n<div class=\"jp-relatedposts\" id=\"jp-relatedposts\">\n<h3 class=\"jp-relatedposts-headline\"><em>Related</em></h3>\n</div>\n<!-- Share buttons by mashshare.net - Version: 4.0.47-->\n<div style=\"border: 1px solid; background: none repeat scroll 0 0 #EDEDED; margin: 1px; font-size: 13px;\">\n<div style=\"text-align: center;\">To <strong>leave a comment</strong> for the author, please follow the link and comment on their blog: <strong><a href=\"https://pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/faster_clinical_trial_reporting.html\"> pharmaverse blog</a></strong>.</div>\n<hr/>\n<a href=\"https://www.r-bloggers.com/\" rel=\"nofollow\">R-bloggers.com</a> offers <strong><a href=\"https://feedburner.google.com/fb/a/mailverify?uri=RBloggers\" rel=\"nofollow\">daily e-mail updates</a></strong> about <a href=\"https://www.r-project.org/\" rel=\"nofollow\" title=\"The R Project for Statistical Computing\">R</a> news and tutorials about <a href=\"https://www.r-bloggers.com/how-to-learn-r-2/\" rel=\"nofollow\" title=\"R tutorials\">learning R</a> and many other topics. <a href=\"https://www.r-users.com/\" rel=\"nofollow\" title=\"Data science jobs\">Click here if you're looking to post or find an R/data-science job</a>.\n\n<hr/>Want to share your content on R-bloggers?<a href=\"https://www.r-bloggers.com/add-your-blog/\" rel=\"nofollow\"> click here</a> if you have a blog, or <a href=\"http://r-posts.com/\" rel=\"nofollow\"> here</a> if you don't.\n</div> </div>\n</article>",
    "main_text": "Faster Clinical Trial Reporting: A Beginner’s Guide to Implementing CDISC SDTM and ADaM Standards with Open-Source R Packages\nPosted on\nSeptember 11, 2025\nby\nFabian Hee\nin\nR bloggers\n| 0 Comments\n[This article was first published on\npharmaverse blog\n, and kindly contributed to\nR-bloggers\n].  (You can report issue about the content on this page\nhere\n)\nWant to share your content on R-bloggers?\nclick here\nif you have a blog, or\nhere\nif you don't.\nClinical trials are a crucial component of the pharmaceutical industry, providing the evidence needed to demonstrate the safety, efficacy, and overall benefit of new drugs or treatments.\nClinical trials reporting, a detailed process in itself, is guided by regulatory agencies like the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the International Conference on Harmonisation (ICH).\nThe results of these trials must be carefully reported to protect public health and foster trust in the pharmaceutical industry. Pharmaverse and R directly support this need by providing open-source, transparent, and standardized tools that enable consistent data handling and reporting.\nCurrent challenges\nClinical trials face several challenges in their current state, which can be broadly categorized into three key areas:\nEthical and Transparency Issues\nInternational ethical standards, including the\nDeclaration of Helsinki\n, emphasize that the results of all clinical trials—whether positive, negative, or inconclusive—should be made publicly accessible. Nevertheless, empirical studies show that compliance remains inconsistent. In particular, early-phase or smaller studies, as well as trials with negative outcomes, are less likely to be reported in a timely or visible manner (\nSOCRA\n;\nBMJ/PMC analysis\n). Furthermore, evidence suggests that industry sponsorship can introduce bias at various stages of trial design, analysis, and reporting, which reinforces the importance of transparent dissemination of all findings (\nCochrane review, 2017\n).\nCost and Efficiency Challenges\nClinical trials are expensive, often exceeding hundreds of millions of dollars, and this can inhibit the development of drugs for rare diseases where the return on investment is limited by the small size of the patient population. Failure in clinical trials – especially in late phase trials that often include upwards of 1000 patients – can incur huge losses, compounded by the complex and varying nature of global regulations around them.\nData and Reproducibility Concerns\nReproducibility is key for independent verification of clinical trial results. Differences in data collection methods, formats, and methodologies often hinder cross-study comparisons, especially if a study was not designed with international standards that are consistent and reproducible.\nPharmaceutical Standards\nThe\nClinical Data Interchange Standards Consortium (CDISC)\nprovides globally accepted data standards, which are a set of guidelines and models used to standardize the collection, exchange, and analysis of clinical trial data. These standards aim to improve efficiency, data quality, and interoperability across various clinical research areas.\nIn this article specifically, the key CDISC Standards we are going to highlight are Clinical Data Acquisition Standards Harmonization (CDASH), Study Data Tabulation Model (SDTM) and Analysis Data Model (ADaM).\nCDASH – Clinical Data Acquisition Standards Harmonization\nCDASH\nprovides\nguidelines for standardized data collection\nacross clinical trial studies. It ensures that data collected at clinical sites is structured, consistent, and easily translatable into regulatory submission formats like SDTM.\nSDTM – Study Data Tabulation Model\nSDTM Implementation Guide\nis a standard for\nstructuring and organizing clinical study datasets\nfor regulatory submissions (e.g., to the FDA, EMA). SDTM data is generally treated by the FDA as the\nraw or source data\n, since it represents the collected study information in a standardized format.\nImportantly, SDTM\nrestructures the collected data\nfor consistency and transparency across studies, but it does\nnot derive or create new analysis variables\n— that role is covered by ADaM.\nADaM – Analysis Data Model\nADaM Implementation Guide\nensures traceability from SDTM data to analysis-ready datasets. This model establishes a\nstandardized way to create datasets for statistical analysis\nfrom SDTM organized data, facilitating efficient analysis and reporting.\nThe Role of R in Clinical Trials\nNowadays, R is widely used in clinical trial analysis due to its flexibility, powerful statistical capabilities, and strong support for regulatory compliance. R provides:\nRobust Statistical Analysis\nused for survival analysis, mixed models, and Bayesian statistics.\nData Cleaning & Transformation\nfacilitated by specialized packages and modeling tools.\nReproducibility & Open Source Solutions\nto ensure that clinical reports and submissions can be automated, reducing errors.\nIntegration with CDISC Standards\nwith the help of various R packages that can structure data according to SDTM and ADaM requirements.\nPharmaverse\nPharmaverse is a collaborative open-source ecosystem of tools for clinical trial data processing and regulatory compliance, currently consisting mainly of R packages but now also including emerging Python software. It provides resources that streamline the implementation of CDISC standards such as SDTM, ADaM, and Define-XML.\nKey Pharmaverse Packages:\n{sdtm.oak}\n– Helps in structuring SDTM datasets.\n{admiral}\n– Facilitates ADaM dataset creation.\n{teal}\n– Builds interactive R/Shiny dashboards for exploratory clinical data analysis.\nRelated R Packages:\n{rtables}\n– Creates regulatory-compliant tables for clinical reports.\n{tern}\n– Creates regulatory-compliant tables/graphs for clinical reports.\nThese are not the only packages that are used, but these are the ones that will be referenced within this blogpost.\nPharmaverse doesn’t have a dedicated CDASH package, but its metadata-driven approach means you can still work with CDASH concepts to connect source data collection to SDTM mapping.\nA more comprehensive list of packages can be found here:\nhttps://pharmaverse.org/e2eclinical/\nData Pipeline\nIn Clinical Trial Reporting, the data pipeline could follow this standard:\nThe raw data from patients is collected according to CDASH guidelines, then processed with SDTM and ADaM standards to produce related Tables, Listings, and Graphs/Figures outputs that correspond to all aspects of a specific clinical trial.\nStarting with the\nCDASH data\nfrom a study, the preparation process starts with\n{sdtm.oak}\nand\n{sdtmchecks}\npackages from the Pharmaverse in order to get them ready for SDTM formatted datasets.\nSubsequently, ADaM standards are applied on this data using the\n{admiral}\npackage, which can then be analysed and transformed into Tables, Listings, and Graphs/Figures using non-pharmaverse (but still related) packages such as\n{rtables}\nand\n{tern}\n.\nThe Pharmaverse contains some repositories with test data that can help visualize and make sense of this, namely\npharmaversesdtm\nand\npharmaverseadam\n.\nThere is also the\n{random.cdisc.data}\npackage that can be used to generate randomized CDISC data for exploratory purposes.\nMore information about these datasets can be found in their respective documentation sites.\nTables, Listings, Graphs/Figures\nThe content of clinical trial reports contains 3 different types of outputs:\nTables\nListings\nGraphs/Figures\nThese outputs play a vital part to summarize the results of a clinical trial during reporting. They can summarize safety, efficacy, and exploratory outcomes (such as biomarker analyses).\nIn the next sections, we will be using the datasets in the\n{random.cdisc.data}\npackage to help create example outputs used in clinical trials reports. These will be split into two sections each, namely “Data Setup” and “Standard Output Generation”.\nTables\nIn this example, we will be creating a\nStandard Adverse Events Table (AET02)\nusing the\ncadsl\nand\ncadae\ndatasets from the\nrandom.cdisc.data\npackage (see the\nTLG Catalogue\nfor reference).\n> Adverse Events Table – AET02\nData Setup:\nlibrary(random.cdisc.data)\nlibrary(dplyr)\nlibrary(tern)\n\n# Ensure character variables are converted to factors so that\n# empty strings and NAs are explicit missing levels.\n\nadsl <- df_explicit_na(cadsl)\nadae <- df_explicit_na(cadae) %>%\n  var_relabel(\n    AEBODSYS = \"MedDRA System Organ Class\",\n    AEDECOD = \"MedDRA Preferred Term\"\n  ) %>%\n  filter(ANL01FL == \"Y\")\n\n# Define the split function\nsplit_fun <- drop_split_levels\nAET02 Output Generation:\n# Standard Table for AET02 --------------------------------------------------------------\nlyt <- basic_table(show_colcounts = TRUE) %>%\n  split_cols_by(var = \"ACTARM\") %>%\n  add_overall_col(label = \"All Patients\") %>%\n  analyze_num_patients(\n    vars = \"USUBJID\",\n    .stats = c(\"unique\", \"nonunique\"),\n    .labels = c(\n      unique = \"Total number of patients with at least one adverse event\",\n      nonunique = \"Overall total number of events\"\n    )\n  ) %>%\n  split_rows_by(\n    \"AEBODSYS\",\n    child_labels = \"visible\",\n    nested = FALSE,\n    split_fun = split_fun,\n    label_pos = \"topleft\",\n    split_label = obj_label(adae$AEBODSYS)\n  ) %>%\n  summarize_num_patients(\n    var = \"USUBJID\",\n    .stats = c(\"unique\", \"nonunique\"),\n    .labels = c(\n      unique = \"Total number of patients with at least one adverse event\",\n      nonunique = \"Total number of events\"\n    )\n  ) %>%\n  count_occurrences(\n    vars = \"AEDECOD\",\n    .indent_mods = -1L\n  ) %>%\n  append_varlabels(adae, \"AEDECOD\", indent = 1L)\n\nresult <- build_table(lyt, df = adae, alt_counts_df = adsl)\n\nresult\nListings\nIn this example, we will be creating a\nStandard Listing of Preferred Terms, Lowest Level Terms, and Investigator-Specified Adverse Event Terms\n(AEL01)\nusing the\n{cadae}\ndataset from the\n{random.cdisc.data}\npackage.\n> Listing of Preferred Terms, Lowest Level Terms, and Investigator-Specified Adverse Event Terms - AEL01\nData Setup:\nlibrary(random.cdisc.data)\nlibrary(dplyr)\nlibrary(rlistings)\n\nout <- cadae %>%\n  select(AESOC, AEDECOD, AELLT, AETERM) %>%\n  unique()\n\nvar_labels(out) <- c(\n  AESOC = \"MedDRA System Organ Class\",\n  AEDECOD = \"MedDRA Preferred Term\",\n  AELLT = \"MedDRA Lowest Level Term\",\n  AETERM = \"Investigator-Specified\\nAdverse Event Term\"\n)\nAEL01 Output Generation:\n# Standard Listing for AEL01 ------------------------------------------------------------\nlsting <- as_listing(\n  out,\n  key_cols = c(\"AESOC\", \"AEDECOD\", \"AELLT\"),\n  disp_cols = names(out),\n  main_title = \"Listing of Preferred Terms, Lowest Level Terms, and Investigator-Specified Adverse Event Terms\"\n)\n\nhead(lsting, 20)\nGraphs/Figures\nIn this example, we will be creating a\nStandard Plot for Subgroup Analysis of Survival Duration (FSTG02)\nusing the\n{caddtte}\ndataset from the\n{random.cdisc.data}\npackage.\nSubgroup Analysis of Survival Duration - FSTG02\">\n> Subgroup Analysis of Survival Duration - FSTG02\nData Setup:\nlibrary(random.cdisc.data)\nlibrary(tern)\nlibrary(dplyr)\nlibrary(forcats)\nlibrary(nestcolor)\n\npreprocess_adtte <- function(adtte) {\n  # Save variable labels before data processing steps.\n  adtte_labels <- var_labels(adtte)\n\n  adtte <- adtte %>%\n    df_explicit_na() %>%\n    dplyr::filter(\n      PARAMCD == \"OS\",\n      ARM %in% c(\"B: Placebo\", \"A: Drug X\"),\n      SEX %in% c(\"M\", \"F\")\n    ) %>%\n    dplyr::mutate(\n      # Reorder levels of ARM to display reference arm before treatment arm.\n      ARM = droplevels(forcats::fct_relevel(ARM, \"B: Placebo\")),\n      SEX = droplevels(SEX),\n      is_event = CNSR == 0,\n      # Convert time to MONTH\n      AVAL = day2month(AVAL),\n      AVALU = \"Months\"\n    ) %>%\n    var_relabel(\n      ARM = adtte_labels[\"ARM\"],\n      SEX = adtte_labels[\"SEX\"],\n      is_event = \"Event Flag\",\n      AVAL = adtte_labels[\"AVAL\"],\n      AVALU = adtte_labels[\"AVALU\"]\n    )\n\n  adtte\n}\n\nanl <- cadtte %>%\n  preprocess_adtte()\nFSTG02 Output Generation:\n# Standard Plot for FSTG02 -------------------------------------------------------\nanl1 <- anl\n\ndf <- extract_survival_subgroups(\n  variables = list(tte = \"AVAL\", is_event = \"is_event\", arm = \"ARM\", subgroups = c(\"SEX\", \"BMRKR2\")),\n  data = anl1\n)\n\nresult <- basic_table() %>%\n  tabulate_survival_subgroups(\n    df = df,\n    vars = c(\"n_tot\", \"n\", \"median\", \"hr\", \"ci\"),\n    time_unit = anl1$AVALU[1]\n  )\n\nresult\n\nplot <- g_forest(tbl = result)\n\nplot\nConclusion\nConclusion\nClinical trial reporting remains fundamental to public trust and to the integrity of drug development. Nevertheless, the field continues to face persistent\ntransparency deficits\n,\nescalating costs\n, and\nreproducibility challenges\n.\nAdopting open standards and collaborative platforms—such as the\nPharmaverse\necosystem—together with broader open-source initiatives in R and related technologies, offers a practical path forward. These approaches enable greater transparency, improved efficiency, and rigorous, standards-based data practices that strengthen the scientific foundation of clinical research. Consequently, the level of trust can be further enhanced, and public welfare can be assured.\nJoin us in part 2 of this series where we take a look at interactive clinical trials data analysis using packages that create custom shiny applications specifically for this space.\nResources\nPharmaverse\nCDISC\nTLG Catalog\nLast updated\n2025-09-12 09:11:58.119603\nDetails\nSource\n,\nSession info\nReuse\nCC BY 4.0\nCitation\nBibTeX citation:\n@online{hee2025,\n  author = {Hee, Fabian and Kouretsis, Alexandros and , APPSILON},\n  title = {Faster {Clinical} {Trial} {Reporting:} {A} {Beginner’s}\n    {Guide} to {Implementing} {CDISC} {SDTM} and {ADaM} {Standards} with\n    {Open-Source} {R} {Packages}},\n  date = {2025-09-12},\n  url = {https://pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/faster_clinical_trial_reporting.html},\n  langid = {en}\n}\nFor attribution, please cite this work as:\nHee, Fabian, Alexandros Kouretsis, and APPSILON. 2025.\n“Faster\nClinical Trial Reporting: A Beginner’s Guide to Implementing CDISC SDTM\nand ADaM Standards with Open-Source R Packages.”\nSeptember 12,\n2025.\nhttps://pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/faster_clinical_trial_reporting.html\n.\nRelated\nTo\nleave a comment\nfor the author, please follow the link and comment on their blog:\npharmaverse blog\n.\nR-bloggers.com\noffers\ndaily e-mail updates\nabout\nR\nnews and tutorials about\nlearning R\nand many other topics.\nClick here if you're looking to post or find an R/data-science job\n.\nWant to share your content on R-bloggers?\nclick here\nif you have a blog, or\nhere\nif you don't.",
    "meta_description": "Clinical trials are a crucial component of the pharmaceutical industry, providing the evidence needed to demonstrate the safety, efficacy, and overall benefit of new drugs or treatments. Clinical trials reporting, a detailed process in itself,...",
    "meta_keywords": null,
    "og_description": "Clinical trials are a crucial component of the pharmaceutical industry, providing the evidence needed to demonstrate the safety, efficacy, and overall benefit of new drugs or treatments. Clinical trials reporting, a detailed process in itself,...",
    "og_image": "https://pharmaverse.github.io/blog/posts/2025-09-12_faster_clinical_trial_reporting/images/1.png",
    "og_title": "Faster Clinical Trial Reporting: A Beginner’s Guide to Implementing CDISC SDTM and ADaM Standards with Open-Source R Packages | R-bloggers",
    "raw_jsonld_article": null,
    "reading_time_min": 9.9,
    "sitemap_lastmod": null,
    "twitter_description": "Clinical trials are a crucial component of the pharmaceutical industry, providing the evidence needed to demonstrate the safety, efficacy, and overall benefit of new drugs or treatments. Clinical trials reporting, a detailed process in itself,...",
    "twitter_title": "Faster Clinical Trial Reporting: A Beginner’s Guide to Implementing CDISC SDTM and ADaM Standards with Open-Source R Packages | R-bloggers",
    "url": "https://www.r-bloggers.com/2025/09/faster-clinical-trial-reporting-a-beginners-guide-to-implementing-cdisc-sdtm-and-adam-standards-with-open-source-r-packages/",
    "word_count": 1983
  }
}